ImmuneOncia Therapeutics, Inc. (KOSDAQ:424870)
South Korea · Delayed Price · Currency is KRW 11,880
+380 (3.30%)
At close: Jan 16, 2026
ImmuneOncia Therapeutics Market Cap
ImmuneOncia Therapeutics has a market cap or net worth of 858.09 billion as of January 16, 2026.
Market Cap
858.09B
Enterprise Value
826.51B
Revenue
715.75M
Ranking
n/a
PE Ratio
n/a
Stock Price
11,880.00
Market Cap Chart
Since May 19, 2025, ImmuneOncia Therapeutics's market cap has increased from 547.53B to 858.09B, an increase of 56.72%. That is a compound annual growth rate of 95.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 19, 2026 | 858.09B | -11.14% |
| Dec 30, 2025 | 965.63B | 76.36% |
| May 19, 2025 | 547.53B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Electronics | 975.53T |
| SK hynix | 521.98T |
| Hyundai Motor Company | 99.30T |
| LG Energy Solution | 91.49T |
| Samsung Biologics | 90.13T |
| Hanwha Aerospace | 66.83T |
| HD Hyundai Heavy Industries | 65.29T |
| Doosan Enerbility | 61.04T |